ArticleScientific reports2025
Prolonged elevated heart rate and 28-day mortality in acute exacerbations of chronic obstructive pulmonary disease patients insights from the MIMIC-IV database.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prolonged elevated heart rate and 28-day in-hospital mortality in patients with asthma-related critical illness: a multicenter retrospective cohort study.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) represent a significant global health burden, and severe exacerbations are associated with worse prognoses. We defined prolonged elevated heart rate (PeHR) as a heart rate exceeding 100 beats per minute for at least 11 h within any continuous 12-hour period. However, the relationship between PeHR and outcomes in patients with AECOPD remains unclear. We identified AECOPD patients in the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and divided them into two groups according to the presence or absence of PeHR. The primary outcome was 28-day mortality. We evaluated the association between PeHR and 28-day mortality using multivariable Cox proportional-hazards models and propensity-score matching. A total of 931 patients with AECOPD were included, 49.6% of whom were male. PeHR occurred in 30.0% of patients. The overall mean age was 72.1 years, and patients with PeHR were younger than those without (71.1 vs. 72.5 years; P < 0.001). Twenty-eight-day mortality was significantly higher in the PeHR group compared with the non-PeHR group (30.3% vs. 15.8%; P < 0.001). In multivariable Cox regression, PeHR was an independent risk factor for 28-day mortality (hazard ratio, 2.16; 95% CI, 1.62-2.87; P < 0.001). After propensity-score matching, the increased mortality in the PeHR group persisted. Prespecified subgroup analyses showed generally consistent effect sizes across all subgroups. PeHR is independently associated with increased 28-day mortality in patients with AECOPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.